Company profile
Syra Health Corp. Class A Common Stock
OTC: SYRA · Healthcare · Medical - Care Facilities
PublicHQ Carmel, DECIK 0001922335Reports USD
#671 of 1,422 Healthcare companies by revenue32nd-percentile growth
EA Score
51DFH 66DQ 33GM 51SS 38
v0.1 · 65/100 weight · provisional
↑ balance-sheet leverage, Altman-Z · ↓ listing tenure, disclosure history
Methodology →Revenue TTM
$7.6M
Rev growth YoY (TTM)
-5.5%
Net income (FY)
-$896.3k
Employees
89
as of 2026-08-23
Market cap
$9.3M
as of 2026-08-23
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$7.2M$7.2M2025
Net income-$896.3k-$896.3k2025
Operating income-$904.3k-$904.3k2025
Total assets$2.8M$2.8M2025
Liabilities$674.7k$674.7k2025
Equity$2.1M$2.1M2025
Revenue trend
FY2023 – FY2025 · USD
FY23
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Population Health100%
By geography
Not disclosed.
The read
What is Syra Health Corp. Class A Common Stock’s revenue?
Syra Health Corp. Class A Common Stock booked $7.2M in FY2025 revenue, contracting 9.5% year over year — slower than 68% of Healthcare companies we track, at a -12.4% net margin.
Peers · Healthcare
Xenon Pharmaceuticals Inc.56COvid Therapeutics Inc.49DNewtopia Inc.——Medical Imaging Corp.——T2 Biosystems, Inc.——Whitehawk Therapeutics Inc50DKey facts
CEOGregory R. Alexander
SectorHealthcare
IndustryMedical - Care Facilities
HeadquartersCarmel, DE
ExchangeOTC: SYRA
Employees89
IPO date2023-09-29
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.